UC

Uma Charan Mohanty

Active Director Director DIN 10654632
DIN 10654632 First appointment Jun 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Uma Charan Mohanty

Data last updated:

Uma Charan Mohanty is a Director at Enzyvo Bioproducts Private Limited (since 2024) and Director at Clickzyme Biotech Private Limited (since 2024).

DIN 10654632
Primary Designation Director
First Appointment 03 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Enzyvo Bioproducts Private Limited U86201OD2024PTC046121
Director18 Jun 20242024Active
Clickzyme Biotech Private Limited U86201OD2024PTC046022
Director03 Jun 20242024Active

Board colleagues of Uma Charan Mohanty

Directorship timeline

Open interactive timeline →
Clickzyme Biotech Private Limited
Enzyvo Bioproducts Private Limited
Premium access

Shareholding and investment profile for Uma Charan Mohanty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uma Charan Mohanty

Uma Charan Mohanty currently holds 2 directorships: Enzyvo Bioproducts Private Limited (Director, since 18 Jun 2024); Clickzyme Biotech Private Limited (Director, since 03 Jun 2024).

Uma Charan Mohanty was first appointed on 03 Jun 2024 as Director at Clickzyme Biotech Private Limited.

The current boards of Uma Charan Mohanty's companies include Krishna Dev Oruganty (Enzyvo Bioproducts Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available